Investor Kit

Company Profile

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and multiple sclerosis. Acorda markets two FDA-approved therapies, including INBRIJA™ (levodopa inhalation powder).

Stock Chart

Financials

Date Filing Description Download
01/15/20 S-3 Securities Registration Statement (simplified form)
01/15/20 SC 13G Statement of Ownership
01/15/20 8-K Current report filing
01/10/20 SC 13G Statement of Ownership

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *


 
Enter the code shown above.